{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T12:31:27Z","timestamp":1720355487163},"reference-count":41,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1248\/bpb.b18-00411","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T22:21:16Z","timestamp":1543616476000},"page":"1778-1790","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study"],"prefix":"10.1248","volume":"41","author":[{"given":"Haruki","family":"Torii","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Tanizaki","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurina","family":"Omiya","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kamiike","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kobe City Medical Center General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Kume","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. <i>Sleep Med. Rev.<\/i>, <b>6<\/b>, 97\u2013111 (2002).","DOI":"10.1053\/smrv.2002.0186"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. <i>Sleep Med.<\/i>, <b>16<\/b>, 372\u2013378 (2015).","DOI":"10.1016\/j.sleep.2014.12.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pallesen S, Sivertsen B, Nordhus IH, Bjorvatn B. A 10-year trend of insomnia prevalence in the adult Norwegian population. <i>Sleep Med.<\/i>, <b>15<\/b>, 173\u2013179 (2014).","DOI":"10.1016\/j.sleep.2013.10.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Calem M, Bisla J, Begum A, Dewey M, Bebbington PE, Brugha T, Cooper C, Jenkins R, Lindesay J, McManus S, Meltzer H, Spiers N, Weich S, Stewart R. Increased prevalence of insomnia and changes in hypnotics use in England over 15 years: analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity Surveys. <i>Sleep<\/i>, <b>35<\/b>, 377\u2013384 (2012).","DOI":"10.5665\/sleep.1700"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Liu X, Uchiyama M, Kim K, Okawa M, Shibui K, Kudo Y, Doi Y, Minowa M, Ogihara R. Sleep loss and daytime sleepiness in the general adult population of Japan. <i>Psychiatry Res.<\/i>, <b>93<\/b>, 1\u201311 (2000).","DOI":"10.1016\/S0165-1781(99)00119-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kaneita Y, Uchiyama M, Yoshiike N, Ohida T. Associations of usual sleep duration with serum lipid and lipoprotein levels. <i>Sleep<\/i>, <b>31<\/b>, 645\u2013652 (2008).","DOI":"10.1093\/sleep\/31.5.645"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Toyama Y, Chin K, Chihara Y, Takegami M, Takahashi K-I, Sumi K, Nakamura T, Nakayama-Ashida Y, Minami I, Horita S, Oka Y, Wakamura T, Fukuhara S-I, Mishima M, Kadotani H. Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. <i>Chest<\/i>, <b>143<\/b>, 720\u2013728 (2013).","DOI":"10.1378\/chest.12-0338"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. <i>Eur. J. Prev. Cardiol.<\/i>, <b>21<\/b>, 57\u201364 (2014).","DOI":"10.1177\/2047487312460020"},{"key":"9","unstructured":"9) Ministry of Health, Labour and Welfare; Tokyo, Japan: 2018. \u201cAnnual health, labour and welfare report 2017. Overview of the system and the basic statistics.\u201d: \u2039https:\/\/www.mhlw.go.jp\/english\/wp\/wp-hw11\/dl\/01e.pdf\u203a, cited September 5, 2018."},{"key":"10","unstructured":"10) WHO (World Health Organization); Geneva, Switzerland. 2018. \u201cThe top 10 causes of death.\u201d: \u2039http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/\u203a, cited September 5, 2018."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease\u2013six year follow-up experience. The Framingham Study. <i>Ann. Intern. Med.<\/i>, <b>55<\/b>, 33\u201350 (1961).","DOI":"10.7326\/0003-4819-55-1-33"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A, Shimamoto T, Iso H. Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). <i>Prev. Med.<\/i>, <b>52<\/b>, 381\u2013386 (2011).","DOI":"10.1016\/j.ypmed.2011.02.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Miller M, Ginsberg HN, Schaefer EJ. Relative atherogenicity and predictive value of non-High-density lipoprotein cholesterol for coronary heart disease. <i>Am. J. Cardiol.<\/i>, <b>101<\/b>, 1003\u20131008 (2008).","DOI":"10.1016\/j.amjcard.2007.11.046"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Imamura T, Doi Y, Ninomiya T, Hata J, Nagata M, Ikeda F, Mukai N, Hirakawa Y, Yoshida D, Fukuhara M, Kitazono T, Kiyohara Y. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study. <i>Atherosclerosis<\/i>, <b>233<\/b>, 343\u2013348 (2014).","DOI":"10.1016\/j.atherosclerosis.2014.01.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Grundy SM, Cleeman JI, Merz CNB, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. <i>Circulation<\/i>, <b>110<\/b>, 227\u2013239 (2004).","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Li C, Ford ES, Tsai J, Zhao G, Balluz LS, Gidding SS. Serum Non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: The Third National Health and Nutrition Examination Survey linked mortality study. <i>Cardiovasc. Diabetol.<\/i>, <b>10<\/b>, 46 (2011).","DOI":"10.1186\/1475-2840-10-46"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. <i>JAMA<\/i>, <b>251<\/b>, 365\u2013374 (1984).","DOI":"10.1001\/jama.1984.03340270043026"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). <i>Lancet<\/i>, <b>344<\/b>, 1383\u20131389 (1994).","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ; West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. <i>N. Engl. J. Med.<\/i>, <b>333<\/b>, 1301\u20131307 (1995).","DOI":"10.1056\/NEJM199511163332001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. <i>N. Engl. J. Med.<\/i>, <b>372<\/b>, 2387\u20132397 (2015).","DOI":"10.1056\/NEJMoa1410489"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K, Japan Atherosclerosis Society. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan\u20142012 version. <i>J. Atheroscler. Thromb.<\/i>, <b>20<\/b>, 517\u2013523 (2013).","DOI":"10.5551\/jat.15792"},{"key":"22","unstructured":"22) Reiner \u017d, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Reviewers D, Funck-Brentano C, Poldermans D, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL; European Association for Cardiovascular Prevention &amp; Rehabilitation; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). <i>Eur. Heart J.<\/i>, <b>32<\/b>, 1769\u20131818 (2011)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nakazaki C, Noda A, Koike Y, Yamada S, Murohara T, Ozaki N. Association of Insomnia and Short Sleep Duration With Atherosclerosis Risk in the Elderly. <i>Am. J. Hypertens.<\/i>, <b>25<\/b>, 1149\u20131155 (2012).","DOI":"10.1038\/ajh.2012.107"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary heart disease in women. <i>Arch. Intern. Med.<\/i>, <b>163<\/b>, 205\u2013209 (2003).","DOI":"10.1001\/archinte.163.2.205"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Brzezinski A. Melatonin in humans. <i>N. Engl. J. Med.<\/i>, <b>336<\/b>, 186\u2013195 (1997).","DOI":"10.1056\/NEJM199701163360306"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Miyamoto M. Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. <i>CNS Neurosci. Ther.<\/i>, <b>15<\/b>, 32\u201351 (2009).","DOI":"10.1111\/j.1755-5949.2008.00066.x"},{"key":"27","unstructured":"27) Cajochen C. TAK-375 Takeda. <i>Curr. Opin. Investig. Drugs. 2000.<\/i>, <b>6<\/b>, 114\u2013121 (2005)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kozir\u00f3g M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. <i>J. Pineal Res.<\/i>, <b>50<\/b>, 261\u2013266 (2011).","DOI":"10.1111\/j.1600-079X.2010.00835.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nduhirabandi F, du Toit EF, Lochner A. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities? <i>Acta Physiol.<\/i>, <b>205<\/b>, 209\u2013223 (2012).","DOI":"10.1111\/j.1748-1716.2012.02410.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Goyal A, Terry PD, Superak HM, Nell-Dybdahl CL, Chowdhury R, Phillips LS, Kutner MH. Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial. <i>Diabetol. Metab. Syndr.<\/i>, <b>6<\/b>, 124 (2014).","DOI":"10.1186\/1758-5996-6-124"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Borba CPC, Fan X, Copeland PM, Paiva A, Freudenreich O, Henderson DC. Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. <i>J. Clin. Psychopharmacol.<\/i>, <b>31<\/b>, 653\u2013658 (2011).","DOI":"10.1097\/JCP.0b013e31822bb573"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. <i>Science<\/i>, <b>210<\/b>, 1267\u20131269 (1980).","DOI":"10.1126\/science.7434030"},{"key":"33","unstructured":"33) Uzun S, Kozumplik O, Jakovljevi\u0107 M, Sedi\u0107 B. Side effects of treatment with benzodiazepines. <i>Psychiatr. Danub.<\/i>, <b>22<\/b>, 90\u201393 (2010)."},{"key":"34","unstructured":"34) Weaver MF. Prescription Sedative Misuse and Abuse. <i>Yale J. Biol. Med.<\/i>, <b>88<\/b>, 247\u2013256 (2015)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, Park BJ. Zolpidem use and risk of fracture in elderly insomnia patients. <i>J. Prev. Med. Pub. Health<\/i>, <b>45<\/b>, 219\u2013226 (2012).","DOI":"10.3961\/jpmph.2012.45.4.219"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Chan TY, Tang PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. <i>Endocr. Res.<\/i>, <b>21<\/b>, 681\u2013696 (1995).","DOI":"10.1080\/07435809509030483"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Hussain SA-R. Effect of melatonin on cholesterol absorption in rats. <i>J. Pineal Res.<\/i>, <b>42<\/b>, 267\u2013271 (2007).","DOI":"10.1111\/j.1600-079X.2006.00415.x"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. <i>Endocrinology<\/i>, <b>142<\/b>, 4264\u20134271 (2001).","DOI":"10.1210\/endo.142.10.8423"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ramracheya RD, Muller DS, Squires PE, Brereton H, Sugden D, Huang GC, Amiel SA, Jones PM, Persaud SJ. Function and expression of melatonin receptors on human pancreatic islets. <i>J. Pineal Res.<\/i>, <b>44<\/b>, 273\u2013279 (2008).","DOI":"10.1111\/j.1600-079X.2007.00523.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ekmekcioglu C, Thalhammer T, Humpeler S, Mehrabi MR, Glogar HD, H\u00f6lzenbein T, Markovic O, Leibetseder VJ, Strauss-Blasche G, Marktl W. The melatonin receptor subtype MT2 is present in the human cardiovascular system. <i>J. Pineal Res.<\/i>, <b>35<\/b>, 40\u201344 (2003).","DOI":"10.1034\/j.1600-079X.2003.00051.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Mazzucchelli C, Pannacci M, Nonno R, Lucini V, Fraschini F, Stankov BM. The melatonin receptor in the human brain: cloning experiments and distribution studies. <i>Brain Res. Mol. Brain Res.<\/i>, <b>39<\/b>, 117\u2013126 (1996).","DOI":"10.1016\/0169-328X(96)00017-4"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/12\/41_b18-00411\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T12:34:35Z","timestamp":1573043675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/12\/41_b18-00411\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00411","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}